Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment.

Anne Davin-Regli, Jean-Marie Pag��s
Author Information
  1. Anne Davin-Regli: Transporteurs Membranaires, Chimior��sistance et Drug Design, Facult��s de M��decine et Pharmacie, UMR-MD1, IRBA - Aix-Marseille Universit��, Marseille France.
  2. Jean-Marie Pag��s: Transporteurs Membranaires, Chimior��sistance et Drug Design, Facult��s de M��decine et Pharmacie, UMR-MD1, IRBA - Aix-Marseille Universit��, Marseille France.

Abstract

Enterobacter aerogenes and E. cloacae have been reported as important opportunistic and multiresistant bacterial pathogens for humans during the last three decades in hospital wards. These Gram-negative bacteria have been largely described during several outbreaks of hospital-acquired infections in Europe and particularly in France. The dissemination of Enterobacter sp. is associated with the presence of redundant regulatory cascades that efficiently control the membrane permeability ensuring the bacterial protection and the expression of detoxifying enzymes involved in antibiotic degradation/inactivation. In addition, these bacterial species are able to acquire numerous genetic mobile elements that strongly contribute to antibiotic resistance. Moreover, this particular fitness help them to colonize several environments and hosts and rapidly and efficiently adapt their metabolism and physiology to external conditions and environmental stresses. Enterobacter is a versatile bacterium able to promptly respond to the antibiotic treatment in the colonized patient. The balance of the prevalence, E. aerogenes versus E. cloacae, in the reported hospital infections during the last period, questions about the horizontal transmission of mobile elements containing antibiotic resistance genes, e.g., the efficacy of the exchange of resistance genes Klebsiella pneumoniae to Enterobacter sp. It is also important to mention the possible role of antibiotic use in the treatment of bacterial infectious diseases in this E. aerogenes/E. cloacae evolution.

Keywords

References

  1. J Antimicrob Chemother. 2013 Jul;68(7):1551-7 [PMID: 23493314]
  2. J Antimicrob Chemother. 2005 Dec;56(6):1115-7 [PMID: 16260446]
  3. Diagn Microbiol Infect Dis. 2010 Apr;66(4):436-40 [PMID: 20071128]
  4. Presse Med. 1985 Mar 23;14(12):673-6 [PMID: 3157961]
  5. Antimicrob Agents Chemother. 2008 Feb;52(2):786-9 [PMID: 18025119]
  6. Diagn Microbiol Infect Dis. 2009 Mar;63(3):314-8 [PMID: 19216942]
  7. J Gen Microbiol. 1992 Nov;138(11):2347-51 [PMID: 1336033]
  8. Clin Microbiol Rev. 2006 Apr;19(2):382-402 [PMID: 16614254]
  9. J Appl Microbiol. 2002;92 Suppl:65S-71S [PMID: 12000614]
  10. Nat Rev Microbiol. 2008 Dec;6(12):893-903 [PMID: 18997824]
  11. J Clin Microbiol. 1989 Dec;27(12):2887-90 [PMID: 2592552]
  12. Antimicrob Agents Chemother. 2002 Dec;46(12):3817-22 [PMID: 12435682]
  13. Int J Antimicrob Agents. 2013 Feb;41(2):130-6 [PMID: 23280442]
  14. Mol Biol Evol. 2013 Feb;30(2):369-83 [PMID: 23071100]
  15. Future Microbiol. 2012 Jul;7(7):887-902 [PMID: 22827309]
  16. Antimicrob Agents Chemother. 2012 Dec;56(12):6256-66 [PMID: 23006750]
  17. J Clin Microbiol. 1996 Sep;34(9):2163-9 [PMID: 8862578]
  18. J Antimicrob Chemother. 2013 Apr;68(4):954-9 [PMID: 23194721]
  19. Int J Antimicrob Agents. 2013 Jul;42(1):76-9 [PMID: 23664677]
  20. PLoS One. 2008 Sep 12;3(9):e3203 [PMID: 18787654]
  21. Biochem Biophys Res Commun. 1999 Dec 9;266(1):248-51 [PMID: 10581197]
  22. J Hosp Infect. 2001 Nov;49(3):173-82 [PMID: 11716634]
  23. J Med Chem. 2005 Mar 10;48(5):1395-400 [PMID: 15743183]
  24. J Clin Microbiol. 2008 Mar;46(3):1037-44 [PMID: 18234876]
  25. J Clin Microbiol. 1985 Jan;21(1):46-76 [PMID: 3881471]
  26. Antimicrob Agents Chemother. 2005 Apr;49(4):1354-8 [PMID: 15793111]
  27. Biochem J. 2000 May 15;348 Pt 1:223-7 [PMID: 10794735]
  28. Antimicrob Agents Chemother. 1996 Dec;40(12):2854-8 [PMID: 9124854]
  29. Arch Microbiol. 2011 Oct;193(10):759-65 [PMID: 21822795]
  30. Diagn Microbiol Infect Dis. 2005 Aug;52(4):331-6 [PMID: 15994052]
  31. FEMS Microbiol Lett. 1995 Jun 15;129(2-3):273-9 [PMID: 7541759]
  32. Int J Antimicrob Agents. 2006 Jun;27(6):549-52 [PMID: 16697150]
  33. JPEN J Parenter Enteral Nutr. 1991 Jul-Aug;15(4):474-5 [PMID: 1910114]
  34. Infect Genet Evol. 2013 Mar;14:1-7 [PMID: 23220359]
  35. Curr Drug Targets. 2008 Sep;9(9):750-9 [PMID: 18781921]
  36. Int J Antimicrob Agents. 2010 Oct;36(4):313-8 [PMID: 20688487]
  37. Antimicrob Agents Chemother. 2002 May;46(5):1183-9 [PMID: 11959543]
  38. Open Microbiol J. 2013;7:22-33 [PMID: 23569467]
  39. Int J Antimicrob Agents. 1997 Jan;9(3):165-7 [PMID: 9552712]
  40. Ann Clin Lab Sci. 2009 Winter;39(1):55-9 [PMID: 19201742]
  41. Infect Control Hosp Epidemiol. 1995 Apr;16(4):224-30 [PMID: 7636170]
  42. Rev Sci Tech. 2012 Apr;31(1):89-104 [PMID: 22849270]
  43. Future Microbiol. 2007 Oct;2(5):501-12 [PMID: 17927473]
  44. Microb Drug Resist. 2013 Apr;19(2):94-9 [PMID: 23206280]
  45. Antimicrob Agents Chemother. 2005 Nov;49(11):4716-20 [PMID: 16251316]
  46. J Antimicrob Chemother. 2005 May;55(5):634-8 [PMID: 15761066]
  47. J Clin Microbiol. 2000 Mar;38(3):1048-52 [PMID: 10698994]
  48. Antimicrob Agents Chemother. 2007 Sep;51(9):3247-53 [PMID: 17638702]
  49. Antimicrob Agents Chemother. 2007 Sep;51(9):3190-8 [PMID: 17606680]
  50. Am J Infect Control. 2001 Apr;29(2):94-8 [PMID: 11287876]
  51. Antimicrob Agents Chemother. 2007 Dec;51(12):4466-70 [PMID: 17938184]
  52. J Antimicrob Chemother. 2014 Oct;69(10):2706-12 [PMID: 24942333]
  53. PLoS One. 2012;7(6):e37967 [PMID: 22719857]
  54. Eur J Clin Microbiol Infect Dis. 1996 Jun;15(6):517-21 [PMID: 8839650]
  55. Infect Control Hosp Epidemiol. 2010 Nov;31 Suppl 1:S7-10 [PMID: 20929376]
  56. Am J Infect Control. 2014 Apr;42(4):456-8 [PMID: 24679578]
  57. Antimicrob Agents Chemother. 2004 Jun;48(6):2153-8 [PMID: 15155215]
  58. J Appl Microbiol. 2003;95(4):744-52 [PMID: 12969288]
  59. Clin Microbiol Rev. 1997 Apr;10(2):220-41 [PMID: 9105752]
  60. Antimicrob Agents Chemother. 2002 Apr;46(4):1128-31 [PMID: 11897606]
  61. J Bacteriol. 2005 Jun;187(11):3894-7 [PMID: 15901719]
  62. Antimicrob Agents Chemother. 1991 Jun;35(6):1174-80 [PMID: 1656855]
  63. Am J Med. 1997 Jul;103(1):51-9 [PMID: 9236486]
  64. J Clin Microbiol. 1997 Jan;35(1):152-60 [PMID: 8968898]
  65. J Antimicrob Chemother. 2013 Mar;68(3):558-61 [PMID: 23152484]
  66. Biophys J. 2010 Feb 17;98(4):569-75 [PMID: 20159153]
  67. Antimicrob Agents Chemother. 1988 Jun;32(6):873-6 [PMID: 3415208]
  68. Microb Drug Resist. 2012 Feb;18(1):59-65 [PMID: 21823989]
  69. Biochem Biophys Res Commun. 2004 May 7;317(3):851-6 [PMID: 15081418]
  70. Chemother Res Pract. 2014;2014:972646 [PMID: 25180095]
  71. Antimicrob Agents Chemother. 2009 Apr;53(4):1652-6 [PMID: 19164140]
  72. Clin Infect Dis. 2009 Jan 1;48(1):1-12 [PMID: 19035777]
  73. Antimicrob Agents Chemother. 1993 May;37(5):939-46 [PMID: 8517720]
  74. Antimicrob Agents Chemother. 2000 Nov;44(11):3158-62 [PMID: 11036041]
  75. PLoS One. 2009;4(5):e5453 [PMID: 19434239]
  76. South Med J. 1996 Nov;89(11):1095-6 [PMID: 8903295]
  77. Antimicrob Agents Chemother. 2003 May;47(5):1555-9 [PMID: 12709321]
  78. Nature. 2014 May 22;509(7501):512-5 [PMID: 24747401]
  79. J Antimicrob Chemother. 2009 Apr;63(4):659-67 [PMID: 19233898]
  80. Antimicrob Agents Chemother. 2005 Jul;49(7):3091-4 [PMID: 15980408]
  81. PLoS One. 2012;7(10):e47636 [PMID: 23110085]
  82. Enferm Infecc Microbiol Clin. 2014 Aug-Sep;32(7):469-70 [PMID: 24355605]
  83. J Clin Microbiol. 1996 Jan;34(1):76-9 [PMID: 8748277]
  84. Clin Infect Dis. 1995 Jan;20(1):84-94 [PMID: 7727676]
  85. J Antimicrob Chemother. 2013 May;68(5):1011-8 [PMID: 23349441]
  86. Cell. 2007 Mar 23;128(6):1037-50 [PMID: 17382878]
  87. Antimicrob Agents Chemother. 1998 Mar;42(3):596-600 [PMID: 9517938]
  88. Enferm Infecc Microbiol Clin. 1995 May;13(5):278-82 [PMID: 7779892]
  89. Antimicrob Agents Chemother. 2002 Aug;46(8):2640-3 [PMID: 12121946]
  90. J Antimicrob Chemother. 2006 Jun;57(6):1223-6 [PMID: 16606635]
  91. Pathol Biol (Paris). 2013 Apr;61(2):38-43 [PMID: 22483784]
  92. Clin Infect Dis. 2000 Jan;30(1):35-40 [PMID: 10619730]
  93. Antimicrob Agents Chemother. 2004 Jul;48(7):2518-23 [PMID: 15215103]
  94. Microbiology (Reading). 1998 Nov;144 ( Pt 11):3003-3009 [PMID: 9846735]
  95. Biochemistry. 2010 Aug 17;49(32):6928-35 [PMID: 20604536]
  96. Antimicrob Agents Chemother. 2002 Apr;46(4):1093-7 [PMID: 11897595]
  97. J Clin Microbiol. 1998 Jul;36(7):1846-52 [PMID: 9650923]
  98. FEMS Microbiol Rev. 2012 Mar;36(2):340-63 [PMID: 21707670]
  99. Euro Surveill. 2013 Aug 01;18(31): [PMID: 23929228]
  100. J Clin Microbiol. 1996 Jun;34(6):1474-80 [PMID: 8735101]
  101. Mol Microbiol. 2001 Jul;41(1):189-98 [PMID: 11454211]
  102. J Clin Microbiol. 1999 Jul;37(7):2165-9 [PMID: 10364580]
  103. J Antimicrob Chemother. 2015 Jan;70(1):48-56 [PMID: 25216820]
  104. J Bacteriol. 1991 Jan;173(1):156-60 [PMID: 1987115]
  105. Int J Antimicrob Agents. 2003 Aug;22(2):128-33 [PMID: 12927952]
  106. Clin Microbiol Infect. 2012 Jun;18(6):539-45 [PMID: 21883663]

Word Cloud

Created with Highcharts 10.0.0EnterobacterantibioticcloacaebacterialaerogenesEresistancetreatmentreportedimportantpathogenslasthospitalseveralinfectionsspefficientlymembraneablemobileelementsversatilegenesopportunisticmultiresistanthumansthreedecadeswardsGram-negativebacterialargelydescribedoutbreakshospital-acquiredEuropeparticularlyFrancedisseminationassociatedpresenceredundantregulatorycascadescontrolpermeabilityensuringprotectionexpressiondetoxifyingenzymesinvolveddegradation/inactivationadditionspeciesacquirenumerousgeneticstronglycontributeMoreoverparticularfitnesshelpcolonizeenvironmentshostsrapidlyadaptmetabolismphysiologyexternalconditionsenvironmentalstressesbacteriumpromptlyrespondcolonizedpatientbalanceprevalenceversusperiodquestionshorizontaltransmissioncontainingegefficacyexchangeKlebsiellapneumoniaealsomentionpossibleroleuseinfectiousdiseasesaerogenes/Eevolutionconfrontingtransportersregulationmechanisms

Similar Articles

Cited By